Welcome to our dedicated page for Addus Homecare SEC filings (Ticker: ADUS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Addus HomeCare Corporation filings document a home care provider with personal care, hospice and home health operations. Form 8-K reports furnish quarterly and annual results of operations, Regulation FD disclosures and exhibit press releases, while amended 8-K filings provide acquisition-related financial statements and pro forma information for the completed purchase of Gentiva's personal care business by Addus HealthCare, a wholly owned subsidiary.
Proxy and annual-meeting filings cover board elections, auditor ratification, executive compensation votes and related governance disclosures. The filing record also includes capital-structure, material-event and shareholder-vote disclosures for the company's common stock.
Addus HomeCare Corp executive Heather Brianne Dixon, President and Chief Operating Officer, reported an open-market sale of 288 shares of common stock at $93.77 per share. According to the disclosure, the sale was made under a previously established Rule 10b5-1 trading plan to cover tax obligations arising from the vesting of restricted stock awards. After this transaction, she continues to hold 44,371 shares of Addus HomeCare common stock directly.
Addus HomeCare Corp director Veronica Hill-Milbourne received a grant of restricted common shares as equity compensation. She acquired 1,449 shares at no stated purchase price, increasing her direct holdings to 6,516 shares. These restricted shares were granted as a non-employee director award and will vest in full on June 10, 2027, aligning part of her compensation with the company’s future performance.
Lopez Esteban reported acquisition or exercise transactions in this Form 4 filing.
Addus HomeCare Corp director Esteban Lopez reported receiving a grant of 1,449 shares of common stock as a compensation award. These are restricted shares for non-employee directors that will vest in full on June 10, 2027. After the award, Lopez directly holds 4,649 shares.
RUSH JEAN reported acquisition or exercise transactions in this Form 4 filing.
Addus HomeCare Corp director Jean Rush received an equity grant of company stock. The Form 4 reports an award of 1,449 shares of Common Stock at no cash cost, increasing her directly held stake to 10,670 shares after the transaction.
According to the footnote, these are restricted shares granted to non-employee directors that will vest in full on June 10, 2027, meaning they are subject to service-based conditions until that date.
Weaver Susan T reported acquisition or exercise transactions in this Form 4 filing.
Addus HomeCare Corp director Susan T. Weaver received a grant of 1,449 shares of restricted common stock as compensation. These restricted shares were granted to a non-employee director and will vest in full on June 10, 2027. Following this award, Weaver directly holds 13,744 shares of Addus HomeCare common stock.
Addus HomeCare Corp director Darin J. Gordon received 1,449 shares of common stock as a restricted stock grant. The award carries no cash exercise price and increases his direct holdings to 14,244 shares. The restricted shares were granted as compensation for non-employee director service and will vest in full on June 10, 2027.
FIRST MARK L reported acquisition or exercise transactions in this Form 4 filing.
Addus HomeCare Corp director Mark L. First received a grant of 1,449 shares of common stock as restricted shares for his service as a non-employee director. These restricted shares were granted at no cash cost to him and will vest in full on June 10, 2027. Following this compensation award, he directly holds 15,070 shares of Addus HomeCare common stock.
Addus HomeCare Corp director Michael Earley reported a compensation-related stock grant. He received an award of 1,449 shares of common stock at no cash cost, described as restricted shares granted to non-employee directors that will vest in full on June 10, 2027.
Following this grant, Earley directly holds 13,400 common shares. In addition, 2,695 common shares are reported as indirectly held by Bird Asset Management, LP. The filing reflects an acquisition by grant rather than any open-market buying or selling.
Addus HomeCare Corporation reported the results of its 2026 annual stockholder meeting. Stockholders representing 17,557,334 shares of common stock, out of 18,664,776 shares outstanding and entitled to vote, were present in person or by proxy. They elected Michael Earley and Veronica Hill-Milbourne as Class II directors with terms expiring at the 2029 annual meeting, ratified PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026, and approved on an advisory, non-binding basis the compensation of the company’s named executive officers as described in the proxy statement.
Addus HomeCare Corp director Esteban Lopez sold shares in an open-market transaction. On May 21, 2026, he sold 250 shares of Addus HomeCare common stock at a price of $93.00 per share. Following this sale, he directly owns 3,200 shares of the company’s common stock.